![Spiros D. Garbis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Spiros D. Garbis
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Proteas Bioanalytics, Inc.
![]() Proteas Bioanalytics, Inc. Internet Software/ServicesTechnology Services Proteas Bioanalytics, Inc. is an innovative proteomics platform that advances molecular biology, biomarker development, and precision medicine. The private company is based in Torrance, CA and was founded by Spiros D. Garbis and Antigoni Manousopoulou. The company provides proteomics services and solutions to unmet needs in the field of neurodegenerative disorders, coronary artery disease, and cancer. Proteas Bioanalytics has collaborated with thought leaders and innovators in the medical field to develop novel blood biomarkers that are predictive of the progression from pre-malignant to active myeloma. Spiros D. Garbis has been the CEO since incorporation. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | - | - | |
Hoofd Techniek/Wetenschap/O&O | - | - | |
Oprichter | - | - | |
President | - | - |
Loopbaan van Spiros D. Garbis
Statistieken
Internationaal
Verenigde Staten | 2 |
Operationeel
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Proteas Bioanalytics, Inc.
![]() Proteas Bioanalytics, Inc. Internet Software/ServicesTechnology Services Proteas Bioanalytics, Inc. is an innovative proteomics platform that advances molecular biology, biomarker development, and precision medicine. The private company is based in Torrance, CA and was founded by Spiros D. Garbis and Antigoni Manousopoulou. The company provides proteomics services and solutions to unmet needs in the field of neurodegenerative disorders, coronary artery disease, and cancer. Proteas Bioanalytics has collaborated with thought leaders and innovators in the medical field to develop novel blood biomarkers that are predictive of the progression from pre-malignant to active myeloma. Spiros D. Garbis has been the CEO since incorporation. | Technology Services |
- Beurs
- Insiders
- Spiros D. Garbis
- Ervaring